We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $2.58B
1-Year Est. Return 68.51%
This Fund
S&P 500
This Quarter Est. Return
+17.15%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$3.85B
AUM Growth
+$644M
Cap. Flow
+$259M
Cap. Flow %
6.72%
Top 10 Hldgs %
76.02%
Holding
40
New
9
Increased
6
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$96.6M
2
B
Barrick Mining
B
+$50.7M
3
THRY icon
Thryv Holdings
THRY
+$34.1M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$32.1M
5
AEL
American Equity Investment Life Holding Company
AEL
+$27.6M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$68.5M
2
AU icon
AngloGold Ashanti
AU
+$24M
3
QGEN icon
Qiagen
QGEN
+$20.8M
4
TCO
Taubman Centers Inc.
TCO
+$13M
5
LEA icon
Lear
LEA
+$1.1M

Sector Composition

Rank Sector Weight
1 Healthcare 46.67%
2 Materials 19.3%
3 Financials 10.73%
4 Communication Services 9.61%
5 Miscellaneous 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$585M 15.17%
7,991,440
+1,300,001
+19% +$96.6M
BHC icon
2
Bausch Health
BHC
$2.45B
$537M 13.95%
25,839,035
– –
AAMI
3
Acadian Asset Management
AAMI
$3.32B
$386M 10.01%
20,000,552
– –
GLD icon
4
SPDR Gold Trust
GLD
$149B
$338M 8.77%
1,894,252
– –
VTRS icon
5
Viatris
VTRS
$19.4B
$215M 5.58%
11,478,260
– –
NG icon
6
NovaGold Resources
NG
$3.54B
$215M 5.58%
22,226,300
– –
TAK icon
7
Takeda Pharmaceutical
TAK
$58.9B
$206M 5.34%
11,295,846
– –
DISCK
8
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$181M 4.69%
6,902,805
– –
AU icon
9
AngloGold Ashanti
AU
$55.2B
$135M 3.51%
5,974,331
-1,000,000
-14% -$24M
ENDP
10
DELISTED
Endo International plc
ENDP
$132M 3.42%
18,327,012
+3,829,443
+26% +$20M
DISH
11
DELISTED
DISH Network Corp.
DISH
$117M 3.04%
3,620,750
– –
THM
12
International Tower Hill Mines
THM
$657M
$85.5M 2.22%
61,930,724
– –
PCRX icon
13
Pacira BioSciences
PCRX
$1.05B
$84.6M 2.2%
1,413,854
+158,246
+13% +$9.27M
B
14
Barrick Mining
B
$73.7B
$80.8M 2.1%
3,546,772
+2,000,000
+129% +$50.7M
KL
15
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$79M 2.05%
1,502,853
– –
PARA
16
DELISTED
Paramount Global Class B
PARA
$58.5M 1.52%
1,569,920
– –
THRY icon
17
Thryv Holdings
THRY
$92.4M
$43.4M 1.13%
+3,216,437
New +$34.1M
ALXN
18
DELISTED
Alexion Pharmaceuticals
ALXN
$39.1M 1.01%
+250,000
New +$32.1M
RP
19
DELISTED
RealPage, Inc.
RP
$34.9M 0.91%
+400,000
New +$26.2M
SA
20
Seabridge Gold
SA
$3.43B
$33.1M 0.86%
1,570,000
+870,000
+124% +$16.8M
TMQ
21
Trilogy Metals
TMQ
$570M
$28.7M 0.74%
14,326,996
– –
AEL
22
DELISTED
American Equity Investment Life Holding Company
AEL
$27.7M 0.72%
+1,000,000
New +$27.6M
PVG
23
DELISTED
PRETIUM RESOURCES INC.
PVG
$27.6M 0.72%
2,400,000
– –
SSRM icon
24
SSR Mining
SSRM
$7.58B
$26.3M 0.68%
1,310,242
– –
EQX icon
25
Equinox Gold
EQX
$15B
$25.9M 0.67%
2,500,000
– –
1
2

Similar funds

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.57B AUM 21.7% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
CTA
Chesley Taft & Associates Chicago, Illinois $2.57B AUM 22.93% 1-Year Est. Return
VWM
Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

Paulson & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Paulson & Co held 40 positions worth $3.85B, up 20% from $3.21B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Paulson & Co deployed $259M of net new capital in Q4 2020, opening 9 new positions and adding to 6 existing holdings. Its largest new stake was Thryv Holdings: 3,216,437 shares worth $43.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 45% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was AngloGold Ashanti, an estimated $24M trimmed.

  • Paulson & Co's largest Q4 2020 buy was Thryv Holdings: 3,216,437 shares worth $43.4M.
  • Paulson & Co added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020, an estimated $96.6M increase.
  • Paulson & Co's biggest Q4 2020 reduction was AngloGold Ashanti, cutting an estimated $24M.
  • Paulson & Co fully exited Tiffany & Co. in Q4 2020, selling an estimated $68.5M.
  • Paulson & Co's ten largest holdings make up 76% of its $3.85B portfolio in Q4 2020.
  • Paulson & Co opened 9 new positions and closed 4 in Q4 2020.
  • Paulson & Co's portfolio value rose 20% quarter-over-quarter to $3.85B.

Based on Paulson & Co's 13F filing for Q4 2020, filed 16 Feb 2021.